In particular, the μR-mediated opioid signaling pathway plays a key role in stress coping and has anti-stress effects, such as reducing the risk of developing depression and attenuating stress-induced anxiety (Bali et al., 2015; Valentino and Van Bockstaele, 2015). This evidence concerns the gene NR3C2 and major depressive disorder.